SSII
SS Innovations International, Inc.
Price Chart
Latest Quote
$3.47
| Previous Close | $3.29 |
| Open | $3.31 |
| Day High | $3.59 |
| Day Low | $3.30 |
| Volume | 49,207 |
Stock Information
| Shares Outstanding | 200.13M |
| Total Debt | $13.82M |
| Cash Equivalents | $15.98M |
| Revenue | $48.47M |
| Net Income | $-10.03M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $694.46M |
| EPS (TTM) | $-0.05 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $692.30M |
| Sales | $48.47M |
| Income | $-10.03M |
| Book/sh | $0.20 |
| Cash/sh | $0.08 |
| Employees | 483 |
Financial Ratios
| Quick Ratio | 1.39 |
| Current Ratio | 2.54 |
| Debt/Eq | 25.34 |
Returns & Margins
| ROA | -4.80% |
| ROE | -21.10% |
| Gross Margin | 49.08% |
| Operating Margin | -32.78% |
| Profit Margin | -20.69% |
Ownership
| Insider Ownership | 80.21% |
| Institutional Ownership | 0.87% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -57.83 |
| P/S | 14.33 |
| P/B | 17.61 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $7.00 |
Technical Indicators
| SMA20 | $3.71 |
| SMA50 | $4.06 |
| SMA200 | $5.41 |
| RSI | 38.07 |
| ATR | 0.3079 |
| Shares Float | 40.32M |
| Short Float | 0.09% |
| Short Ratio | 1.05 |
| Volatility | 0.43 |
| Rel Volume | 0.72 |
Performance History
| Week | -1.70% |
| Month | -13.25% |
| Quarter | -30.74% |
| 6 Months | -36.91% |
| YTD | -38.58% |
| Year | +1.46% |
| 10 Years | -13.25% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $3.47 | 49,500 |
| 2026-06-17 | $3.29 | 53,900 |
| 2026-06-16 | $3.47 | 25,900 |
| 2026-06-15 | $3.52 | 93,100 |
| 2026-06-12 | $3.36 | 41,000 |
| 2026-06-11 | $3.53 | 66,600 |
| 2026-06-10 | $3.52 | 33,100 |
| 2026-06-09 | $3.56 | 69,300 |
| 2026-06-08 | $3.53 | 79,400 |
| 2026-06-05 | $3.78 | 53,900 |
| 2026-06-04 | $3.84 | 133,800 |
| 2026-06-03 | $4.31 | 122,900 |
| 2026-06-02 | $4.01 | 124,700 |
| 2026-06-01 | $3.94 | 49,500 |
| 2026-05-29 | $3.94 | 46,600 |
| 2026-05-28 | $3.95 | 63,100 |
| 2026-05-27 | $3.76 | 86,000 |
| 2026-05-26 | $3.73 | 82,200 |
| 2026-05-22 | $3.89 | 54,500 |
| 2026-05-21 | $3.89 | 38,400 |
| 2026-05-20 | $3.94 | 35,300 |
| 2026-05-19 | $4.00 | 38,000 |
About SS Innovations International, Inc.
SS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India, Philippines, Indonesia, South America, Iraq, Cyprus, Oman, United Arab Emirates (UAE), Nepal, and internationally. It offers SSi Mantra, a surgical robotic system; and SSi Mudra, a range of stapling, energy, and core instrumentations for surgical systems. The company also develops NADI  Automated Coronary Anastomotic Connector, a micro stapling device; SSi Multi-Fire Clip Applier, a cartridge-based clip applicator; SSi Robotic Stapler; SSi Maya is an enabling digital platform that compliments the SSI Mantra system and enhances surgical capabilities; SSi Guru is a virtual tele illustration; SSi XR Cognitive Skill Simulator is an extended reality (XR) software platform developed to train and educate surgeons and surgical assistants; SSi MantraM; SSi Mantra Tele Surgeon Console (TSC); and 5mm surgical instruments; SSi Holographic Anatomy, an augmented reality tool; SSi Chitrasa  Advanced DICOM Viewer, an AI enabled application viewer; and SSi Mixed Reality Headset, a medical-grade device. In addition, it offers instrument tips, including forceps, scissors, electrocautery tools, scalpels, and other surgical tools. Further, the company provides accessory products, such as sterile drapes, 3d stereo endoscopes, cannulas, and seals, as well as tele proctoring and telesurgery products. Additionally, it offers installation, repair, maintenance, 24/7 technical support, and proactive health monitoring services. The company sells its products through direct sales organizations and distributor networks. SS Innovations International, Inc. is headquartered in Gurugram, India.
đ° Latest News
SS Innovations International Insiders Placed Bullish Bets Worth US$5.20m
Simply Wall St. âĸ 2026-06-12T10:43:36ZSS Innovations International, Inc. (SSII) Gains Approvals for SSi Mantra in Key Emerging Markets
Insider Monkey âĸ 2026-04-03T00:06:46ZSS Innovations ramps up in telesurgery; XCath robot treats stroke remotely
MedTech Dive âĸ 2026-03-24T10:00:00ZWhy SS Innovations (SSII) Is Up 10.8% After Telesurgery Milestone And Auditor Going Concern Doubts
Simply Wall St. âĸ 2026-03-23T08:04:57ZSS Innovations raises $18.6M as surgical robot nears US market
MedTech Dive âĸ 2026-03-10T06:48:36ZWhat SS Innovations International (SSII)'s 2025 Revenue Surge and Leadership Shift Means For Shareholders
Simply Wall St. âĸ 2026-01-15T11:06:17ZIs SS Innovations International (SSII) Overvalued After Recent Share Price Rebound And Premium P/S Multiple
Simply Wall St. âĸ 2026-01-14T16:06:28ZSS Innovations International (SSII): Assessing Valuation Following Recent Stock Volatility
Simply Wall St. âĸ 2025-11-08T23:16:50Z3 Emerging Tech Stocks That Could Go Parabolic
Motley Fool âĸ 2025-10-09T10:30:00ZEvaluating SS Innovations International (NasdaqCM:SSII) Valuation as Investor Optimism Grows
Simply Wall St. âĸ 2025-10-02T15:04:44ZIncome Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $22,940,492 | $12,197,162 | $5,149,786 | $1,375,570 |
| Cost Of Revenue | $22,940,492 | $12,197,162 | $5,149,786 | $1,375,570 |
| Total Revenue | $42,484,747 | $20,649,528 | $5,875,314 | $1,436,147 |
| Operating Revenue | $42,484,747 | $20,649,528 | $5,875,314 | $1,436,147 |
| Expenses | ||||
| Interest Expense | $1,108,637 | $973,235 | $894,621 | $265,522 |
| Total Expenses | $50,678,781 | $39,625,490 | $26,149,298 | $4,394,739 |
| Net Non Operating Interest Income Expense | $33,087 | $-175,235 | $-604,308 | $-255,290 |
| Interest Expense Non Operating | $1,108,637 | $973,235 | $894,621 | $265,522 |
| Operating Expense | $27,738,289 | $27,428,328 | $20,999,512 | $3,019,169 |
| General And Administrative Expense | $22,976,542 | $24,500,552 | $19,788,114 | $1,935,149 |
| Other Income Expense | - | - | $120,000 | $279,975 |
| Other Non Operating Income Expenses | - | - | $120,000 | $279,975 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-12,127,387 | $-19,151,197 | $-20,878,292 | $-3,213,882 |
| Net Interest Income | $33,087 | $-175,235 | $-604,308 | $-255,290 |
| Interest Income | $1,141,724 | $798,000 | $290,313 | $10,232 |
| Normalized Income | $-12,127,387 | $-19,151,197 | $-20,878,292 | $-3,213,882 |
| Net Income From Continuing And Discontinued Operation | $-12,127,387 | $-19,151,197 | $-20,878,292 | $-3,213,882 |
| Total Operating Income As Reported | $-8,194,034 | $-18,975,962 | $-20,273,984 | $-2,958,592 |
| Net Income Common Stockholders | $-12,127,387 | $-19,151,197 | $-20,878,292 | $-3,213,882 |
| Net Income | $-12,127,387 | $-19,151,197 | $-20,878,292 | $-3,213,882 |
| Net Income Including Noncontrolling Interests | $-12,127,387 | $-19,151,197 | $-20,878,292 | $-3,213,882 |
| Net Income Continuous Operations | $-12,127,387 | $-19,151,197 | $-20,878,292 | $-3,213,882 |
| Pretax Income | $-8,160,947 | $-19,151,197 | $-20,878,292 | $-3,213,882 |
| Interest Income Non Operating | $1,141,724 | $798,000 | $290,313 | $10,232 |
| Operating Income | $-8,194,034 | $-18,975,962 | $-20,273,984 | $-2,958,592 |
| Depreciation Amortization Depletion Income Statement | $1,075,907 | $436,005 | $152,738 | $96,577 |
| Depreciation And Amortization In Income Statement | $1,075,907 | $436,005 | $152,738 | $96,577 |
| Gross Profit | $19,544,255 | $8,452,366 | $725,528 | $60,577 |
| Depreciation Income Statement | - | - | $152,738 | $96,577 |
| Special Income Charges | - | - | - | - |
| Per Share | ||||
| Diluted EPS | $-0.06 | $-0.11 | $-0.14 | $-0.03 |
| Basic EPS | $-0.06 | $-0.11 | $-0.14 | $-0.03 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-5,976,403 | $-17,741,957 | $-19,830,933 | $-2,851,783 |
| Reconciled Depreciation | $1,075,907 | $436,005 | $152,738 | $96,577 |
| EBITDA (Bullshit earnings) | $-5,976,403 | $-17,741,957 | $-19,830,933 | $-2,851,783 |
| EBIT | $-7,052,310 | $-18,177,962 | $-19,983,671 | $-2,948,360 |
| Diluted Average Shares | $198,699,461 | $181,203,673 | $152,069,825 | $128,157,040 |
| Basic Average Shares | $190,009,159 | $170,847,444 | $144,866,674 | $128,157,040 |
| Diluted NI Availto Com Stockholders | $-12,127,387 | $-19,151,197 | $-20,878,292 | $-3,213,882 |
| Tax Provision | $3,966,440 | $0 | $0 | $0 |
| Research And Development | $3,685,840 | $2,491,771 | $1,058,660 | $987,443 |
| Selling General And Administration | $22,976,542 | $24,500,552 | $19,788,114 | $1,935,149 |
| Other Gand A | $14,848,439 | $10,157,768 | $10,064,622 | $1,935,149 |
| Salaries And Wages | $8,128,103 | $14,342,784 | $9,723,492 | $0 |
| Total Unusual Items | - | - | - | - |
| Total Unusual Items Excluding Goodwill | - | - | - | - |
| Gain On Sale Of Security | - | - | - | - |
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $38,218,251 | $13,457,103 | $19,718,078 | $-2,678,537 |
| Total Assets | $74,226,217 | $42,385,213 | $31,515,994 | $6,980,533 |
| Total Non Current Assets | $25,425,558 | $14,968,922 | $10,087,335 | $2,885,298 |
| Other Non Current Assets | $458,964 | $318,527 | $35,919 | - |
| Non Current Prepaid Assets | $2,601,058 | $3,341,528 | $4,322,444 | $83,912 |
| Non Current Deferred Assets | $533,727 | $0 | - | - |
| Non Current Deferred Taxes Assets | $533,727 | $0 | - | - |
| Non Current Accounts Receivable | $9,977,243 | $3,299,032 | $2,365,013 | $886,263 |
| Current Assets | $48,800,659 | $27,416,291 | $21,428,659 | $4,095,235 |
| Restricted Cash | $5,937,650 | $5,838,508 | $5,029,650 | $57,448 |
| Prepaid Assets | $4,361,735 | $3,746,538 | $3,552,717 | $423,994 |
| Inventory | $17,064,002 | $10,206,898 | $7,017,913 | $904,103 |
| Receivables | $18,230,866 | $7,157,847 | $3,806,103 | $2,492,513 |
| Other Receivables | $5,832,324 | $2,691,800 | $1,904,859 | $706,817 |
| Accounts Receivable | $12,398,542 | $4,466,047 | $1,901,244 | $156,857 |
| Cash Cash Equivalents And Short Term Investments | $3,206,406 | $466,500 | $2,022,276 | $217,177 |
| Cash And Cash Equivalents | $3,206,406 | $466,500 | $2,022,276 | $217,177 |
| Cash Financial | $3,206,406 | $466,500 | - | - |
| Goodwill And Other Intangible Assets | - | - | $36,122 | $36,122 |
| Other Intangible Assets | - | - | $36,122 | $36,122 |
| Other Current Assets | - | - | $3,375,169 | $700,920 |
| Notes Receivable | - | - | $0 | $3,000,000 |
| Gross Accounts Receivable | - | - | $1,647,274 | $592,313 |
| Debt | ||||
| Net Debt | $8,236,542 | $14,978,406 | $4,506,839 | $6,495,766 |
| Total Debt | $14,359,814 | $18,203,542 | $9,277,012 | $8,265,940 |
| Long Term Debt And Capital Lease Obligation | $2,337,697 | $2,349,118 | $2,351,113 | $1,840,114 |
| Current Debt And Capital Lease Obligation | $12,022,117 | $15,854,424 | $6,925,899 | $6,425,826 |
| Current Debt | $11,442,948 | $15,444,906 | $6,529,115 | $6,243,926 |
| Other Current Borrowings | - | - | $510,189 | $120,880 |
| Long Term Debt | - | - | - | $469,017 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $36,007,966 | $28,928,110 | $11,797,916 | $9,659,070 |
| Total Non Current Liabilities Net Minority Interest | $9,766,268 | $7,597,888 | $3,324,196 | $1,892,881 |
| Non Current Deferred Liabilities | $7,139,807 | $5,173,953 | $939,150 | $42,141 |
| Current Liabilities | $26,241,698 | $21,330,222 | $8,473,720 | $7,766,189 |
| Current Deferred Liabilities | $3,266,686 | $1,278,602 | $156,330 | $1,776 |
| Current Notes Payable | $0 | $7,450,000 | $0 | $3,000,000 |
| Payables And Accrued Expenses | $10,952,895 | $4,197,196 | $1,391,491 | $1,338,587 |
| Payables | $5,240,134 | $2,459,906 | $1,034,077 | $840,490 |
| Other Payable | $112,941 | $147,524 | $83,365 | - |
| Accounts Payable | $5,127,193 | $2,312,382 | $950,712 | $165,477 |
| Other Current Liabilities | - | - | $-1 | - |
| Current Deferred Taxes Liabilities | - | - | $20,482 | $20,597 |
| Other Non Current Liabilities | - | - | - | $-1 |
| Interest Payable | - | - | - | $45,529 |
| Equity | ||||
| Common Stock Equity | $38,218,250 | $13,457,102 | $19,718,077 | $-2,678,537 |
| Preferred Stock Equity | $1 | $1 | $1 | - |
| Total Equity Gross Minority Interest | $38,218,251 | $13,457,103 | $19,718,078 | $-2,678,537 |
| Stockholders Equity | $38,218,251 | $13,457,103 | $19,718,078 | $-2,678,537 |
| Gains Losses Not Affecting Retained Earnings | $-1,122,743 | $150,292 | $704,418 | $954,516 |
| Other Equity Adjustments | $-1,122,743 | $150,292 | $704,418 | $954,516 |
| Retained Earnings | $-55,789,934 | $-43,662,547 | $-24,511,350 | $-3,633,058 |
| Other | ||||
| Ordinary Shares Number | $194,165,141 | $171,579,284 | $170,711,880 | $5,388,773 |
| Share Issued | $194,165,141 | $171,579,284 | $170,711,880 | $5,388,773 |
| Tangible Book Value | $38,218,250 | $13,457,102 | $19,718,077 | $-2,678,537 |
| Invested Capital | $49,661,198 | $28,902,008 | $26,247,192 | $4,034,406 |
| Working Capital | $22,558,961 | $6,086,069 | $12,954,939 | $-3,670,954 |
| Capital Lease Obligations | $2,916,866 | $2,758,636 | $2,747,897 | $1,552,997 |
| Total Capitalization | $38,218,251 | $13,457,103 | $19,718,078 | $-2,209,520 |
| Additional Paid In Capital | $95,111,511 | $56,952,200 | $43,457,937 | $-12,812 |
| Capital Stock | $19,417 | $17,158 | $67,073 | $12,817 |
| Common Stock | $19,416 | $17,157 | $67,072 | $12,817 |
| Preferred Stock | $1 | $1 | $1 | $0 |
| Employee Benefits | $188,622 | $74,817 | $33,933 | $10,626 |
| Non Current Pension And Other Postretirement Benefit Plans | $188,622 | $74,817 | $33,933 | $10,626 |
| Non Current Accrued Expenses | $100,142 | $0 | - | - |
| Non Current Deferred Revenue | $7,139,807 | $5,173,953 | $939,150 | $42,141 |
| Long Term Capital Lease Obligation | $2,337,697 | $2,349,118 | $2,351,113 | $1,371,097 |
| Current Deferred Revenue | $3,266,686 | $1,278,602 | $156,330 | $1,776 |
| Current Capital Lease Obligation | $579,169 | $409,518 | $396,784 | $181,900 |
| Line Of Credit | $11,442,948 | $7,994,906 | $6,018,926 | $3,123,046 |
| Current Accrued Expenses | $5,712,761 | $1,737,290 | $357,414 | $498,097 |
| Net PPE | $11,854,566 | $8,009,835 | $3,363,959 | $1,915,123 |
| Accumulated Depreciation | $-1,545,923 | $-645,487 | $-331,841 | $-200,812 |
| Gross PPE | $13,400,489 | $8,655,322 | $3,695,800 | $2,115,935 |
| Leases | $738,955 | $254,468 | $154,651 | $0 |
| Construction In Progress | $0 | $47,592 | $0 | $48,000 |
| Other Properties | $10,162,115 | $7,161,339 | $2,769,987 | $1,627,350 |
| Machinery Furniture Equipment | $2,499,419 | $1,191,923 | $771,162 | $440,585 |
| Properties | $0 | $0 | $0 | $0 |
| Inventories Adjustments Allowances | $-107,708 | $0 | - | - |
| Finished Goods | $8,717,761 | $4,308,750 | $4,975,670 | - |
| Work In Process | $1,426,933 | $1,436,250 | $533,108 | - |
| Raw Materials | $7,027,016 | $4,461,898 | $1,509,135 | - |
| Treasury Shares Number | - | - | $0 | - |
| Minority Interest | - | - | $0 | $0 |
| Foreign Currency Translation Adjustments | - | - | $-329,100 | $15,521 |
| Dueto Related Parties Current | - | - | $0 | $675,013 |
| Duefrom Related Parties Current | - | - | $1,567,559 | $1,628,839 |
| Treasury Stock | - | - | - | $0 |
| Pensionand Other Post Retirement Benefit Plans Current | - | - | - | $0 |
| Investments And Advances | - | - | - | - |
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-22,202,045 | $-10,164,509 | $-15,814,972 | $-5,994,475 |
| Operating Activities | ||||
| Operating Cash Flow | $-18,542,987 | $-9,503,030 | $-15,361,645 | $-5,994,475 |
| Cash Flow From Continuing Operating Activities | $-18,542,987 | $-9,503,030 | $-15,361,645 | $-5,994,475 |
| Operating Gains Losses | - | - | - | - |
| Investing Activities | ||||
| Capital Expenditure | $-3,659,058 | $-661,479 | $-453,327 | $-220,324 |
| Investing Cash Flow | $-3,659,058 | $-661,479 | $-453,327 | $240,818 |
| Cash Flow From Continuing Investing Activities | $-3,659,058 | $-661,479 | $-453,327 | $240,818 |
| Net Other Investing Changes | - | - | $464,029 | $-3,000,000 |
| Financing Activities | ||||
| Financing Cash Flow | $26,166,556 | $9,425,980 | $22,796,286 | $5,896,161 |
| Cash Flow From Continuing Financing Activities | $26,166,556 | $9,425,980 | $22,796,286 | $5,896,161 |
| Issuance Of Capital Stock | - | $0 | $412,056 | $0 |
| Net Common Stock Issuance | - | $0 | $412,056 | $0 |
| Common Stock Issuance | - | $0 | $412,056 | $0 |
| Net Other Financing Charges | - | - | $1,910,432 | - |
| Repurchase Of Capital Stock | - | - | - | - |
| Other | ||||
| Repayment Of Debt | $-5,281,486 | $0 | $-126,505 | $-145,000 |
| Issuance Of Debt | $31,448,042 | $9,425,980 | $22,460,735 | $5,896,161 |
| End Cash Position | $9,603,020 | $6,623,535 | $7,087,845 | $274,625 |
| Beginning Cash Position | $6,623,535 | $7,087,845 | $274,625 | $87,709 |
| Effect Of Exchange Rate Changes | $-985,026 | $274,219 | $-168,094 | $44,412 |
| Changes In Cash | $3,964,511 | $-738,529 | $6,981,314 | $142,504 |
| Net Issuance Payments Of Debt | $26,166,556 | $9,425,980 | $22,334,230 | $5,896,161 |
| Net Short Term Debt Issuance | $3,448,042 | $4,975,980 | $2,480,735 | $2,896,161 |
| Short Term Debt Issuance | $3,448,042 | $4,975,980 | $2,480,735 | $2,896,161 |
| Net Long Term Debt Issuance | $22,718,514 | $4,450,000 | $19,853,495 | $3,000,000 |
| Long Term Debt Payments | $-5,281,486 | $0 | $-126,505 | - |
| Long Term Debt Issuance | $28,000,000 | $4,450,000 | $19,980,000 | $3,000,000 |
| Net PPE Purchase And Sale | $-3,659,058 | $-661,479 | $-453,327 | $240,818 |
| Purchase Of PPE | $-3,659,058 | $-661,479 | $-453,327 | $-220,324 |
| Change In Working Capital | $-15,001,863 | $-6,081,229 | $-9,657,697 | $-3,163,033 |
| Change In Other Working Capital | $3,953,938 | $5,357,075 | $1,051,563 | $-1,158,491 |
| Change In Payables And Accrued Expense | $7,254,063 | $2,554,867 | $1,166,368 | $336,943 |
| Change In Accrued Expense | $161,914 | $1,144,037 | $430,293 | $208,108 |
| Change In Payable | $7,092,149 | $1,410,830 | $736,075 | $128,835 |
| Change In Account Payable | $2,877,810 | $1,410,830 | $736,075 | $128,835 |
| Change In Tax Payable | $4,214,339 | $0 | - | - |
| Change In Income Tax Payable | $4,214,339 | $0 | - | - |
| Change In Prepaid Assets | $-5,101,794 | $-1,411,621 | $-2,690,178 | $-515,890 |
| Change In Inventory | $-8,070,786 | $-7,691,518 | $-6,113,810 | $-780,683 |
| Change In Receivables | $-13,037,284 | $-4,890,032 | $-3,071,640 | $-1,044,912 |
| Changes In Account Receivables | $-13,037,284 | $-4,890,032 | $-3,071,640 | $-1,044,912 |
| Other Non Cash Items | $-318,895 | $-53,611 | $5,288,864 | $285,863 |
| Stock Based Compensation | $8,128,103 | $14,342,784 | $9,723,492 | $0 |
| Provisionand Write Offof Assets | $214,013 | $955,762 | $0 | - |
| Asset Impairment Charge | $0 | $48,456 | $9,250 | - |
| Deferred Tax | $-512,865 | $0 | - | - |
| Deferred Income Tax | $-512,865 | $0 | - | - |
| Depreciation Amortization Depletion | $1,075,907 | $436,005 | $152,738 | $96,577 |
| Depreciation And Amortization | $1,075,907 | $436,005 | $152,738 | $96,577 |
| Depreciation | $1,075,907 | $436,005 | $152,738 | $96,577 |
| Net Income From Continuing Operations | $-12,127,387 | $-19,151,197 | $-20,878,292 | $-3,213,882 |
| Proceeds From Stock Option Exercised | - | $0 | $50,000 | $0 |
| Interest Paid Supplemental Data | - | - | $0 | $0 |
| Income Tax Paid Supplemental Data | - | - | $0 | $0 |
| Short Term Debt Payments | - | - | $-9,051,353 | $-145,000 |
| Sale Of PPE | - | - | $0 | $484,510 |
| Net Business Purchase And Sale | - | - | - | $0 |
| Sale Of Business | - | - | - | $0 |
| Common Stock Payments | - | - | - | - |
| Net Investment Purchase And Sale | - | - | - | - |
| Purchase Of Investment | - | - | - | - |
| Net Intangibles Purchase And Sale | - | - | - | - |
| Purchase Of Intangibles | - | - | - | - |
| Gain Loss On Investment Securities | - | - | - | - |